ACHE and Alzheimer disease: AChE activities were reduced by 85–90% during AD progression, with the ratio between BChE and AChE in the cortical regions changing significantly from 0.2 to 1.0 [41,42], suggesting that AD patients had little residual AChE in the cortex [43]; meanwhile, BChE remained normal or even increased [40].